Beta cell functionality and hepatic insulin resistance are major contributors to type 2 diabetes remission and starting pharmacological therapy: from CORDIOPREV randomized controlled trial

Author:

Roncero-Ramos Irene,Gutierrez-Mariscal Francisco M.,Gomez-Delgado Francisco,Villasanta-Gonzalez Alejandro,Torres-Peña Jose D.,Cruz-Ares Silvia De La,Rangel-Zuñiga Oriol A.,Luque Raul M.,Ordovas Jose M.,Delgado-Lista Javier,Perez-Martinez Pablo,Camargo Antonio,Alcalá-Diaz Juan F.,Lopez-Miranda Jose

Publisher

Elsevier BV

Subject

Biochemistry (medical),Public Health, Environmental and Occupational Health,General Medicine,Physiology (medical)

Reference47 articles.

1. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017;James;Lancet,2018

2. Geneva S. Global report on diabetes. World Health Organization,2016

3. Cardiovascular risk factors clustering with endogenous hyperinsulinaemia predict death from coronary heart disease in patients with Type II diabetes;Lehto;Diabetologia,2000

4. Predicting major adverse limb events in individuals with type 2 diabetes: insights from the EXSCEL trial. Diabetic medicine: a journal of the British Diabetic Association;Weissler,2021

5. Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future;Kahn;Lancet,2014

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3